Who owns JASPER THERAPEUTICS?
- Ticker: JSPRW
- CUSIP Number: 471871111
Tip: Access positions for across all investors
Analyze quarterly positions in Jasper Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Jasper Therapeutics stock
Who bought or sold JASPER THERAPEUTICS this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Toronto-Dominion Bank | 2.2M | $30k | 0% | Jun 2026 |
|
| Boothbay Fund Management | 357k | $151k | 0% | Jun 2026 |
|
| Tenor Capital Management | 250k | $3.4k | 0% | Jun 2026 |
|
| Walleye Trading Advisors | 200k | $2.7k | 0% | Jun 2026 |
|
| Jpmorgan Chase & Co | 2.9k | $39.997600 | 100% | Jun 2026 |
|
| Wolverine Asset Management | 1.6k | $21.962600 | 58% | Jun 2026 |
|
| IFP Advisors | 50.00 | $1.000000 | 0% | Jun 2026 |
|
Who sold out of Jasper Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Susquehanna International | Mar 2026 | 28k | $617.580000 |